Tuesday, February 07, 2012 4:50 PM
FDA Approval for 2 St. Jude Catheters
St. Jude Medical wins pre-market approval for two of its next-generation cardiac ablation systems.
Irvine, CA-based St. Jude Medical Inc. won pre-market approval for 2 next-generation cardiac ablation systems this month—the Therapy Cool Path Duo and Safire Blu Duo catheters. Both ablation systems use radiofrequency energy to freeze small areas of faulty cardiac tissue in patients with typical trial flutter, a type of arrhythmia in which patients experience abnormal heart rhythms or an abnormally fast heartbeat in the upper chambers of the heart. The company also won approval for more...
|
Please log in or become a member...
To continue reading this content you must either log in become a member. If you are already a member, please log in using the form below. If you are not already a member, we invite you to join our online community. Membership is free of charge to personnel working in industry, academia, and government.
To join please click on the "Become a Member" link at the top of the page (joining takes around 1 minute and you only need to register once).
Membership benefits include free access to:
-
Industry news, feature articles, podcasts, videos and blogs
-
Weekly eNewsletter subscription
-
Resource Center including downloadable brochures, white papers, reports & media files
-
Industry events calendar
Thank you!
|
Be the first to leave a comment.
Post your comments about this article or questions for the author here